Somatostatin

Spezifikationen

38916-34-6CAS-Nummer

254-186-5EG-Nummer

(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21IUPAC-Name

C76H104N18O19S2Chemische Formel

1637.9 g/molMolekulargewicht

SOMATOSTATIN; 38916-34-6; Cyclic Somatostatin; Somatostatin-14; Somatostatina; Somatostatine; Somatostatin 14; Somatostatinum; Somatostatin, cyclic; Synthetic somatostatin-14; Somatostatin-1; 6E20216Q0L; Panhibin; CHEBI:64628; SRIF; Somatotropin release-inhibiting factor; DTXSID8046793; AY 24910; DTXCID6026793; SRIH-14; Somatotropin release inhibiting factor; Recombinant Somatostatin; GH-RIH; RefChem:184270; H01CB01; 254-186-5; 256-969-7; (4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-((2-(((2S)-2-aminopropanoyl)amino)acetyl)amino)-13,25,28-tribenzyl-10,16-bis((1R)-1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid; Somatostatin (sheep); Stilamin; SRIF 14; 15-28-Somatostatin-28; Somatostatine [INN-French]; Somatostatinum [INN-Latin]; Somatostatina [INN-Spanish]; Somatostatin (rat); CCRIS 3629; Somatostatin (human); Somatostatin (pigeon); EINECS 254-186-5; Somatostatin [INN:BAN]; UNII-6E20216Q0L; SR 9357; SOMATOSTATIN [MI]; Somatostatin-14 AC Salt; SOMATOSTATIN [INN]; SOMATOSTATIN [MART.]; 38916-34-6free base; SOMATOSTATIN [WHO-DD]; orb1679899; CHEMBL1823872; SCHEMBL21361053; SCHEMBL29350200; BDBM81767; SOMATOSTATIN [EP MONOGRAPH]; EX-A12208; AKOS015994634; AC-8931; DB09099; FS27855; HS-2027; NCGC00167137-01; BP-43728; CAS_38916-34-6; CB6417646; C74981; BRD-K14681867-001-01-6; BRD-K14681867-015-01-6; Q22075835; Ala-Gly-cyclo-[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys]; Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH(Cys3-Cys14); ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS 3,14-disulfide; L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide; L-Alanyl-N-{(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-[(1H-indol-3-yl)methyl]-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl}glycinamide; L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide; Somatostatin-14 (H-L-Ala-L-Gly-L-Cys(1)-L-Lys-L-Asn-L-Phe-L-Phe-L-Trp-L-Lys-L-Thr-L-Phe-L-Thr-L-Ser-L-Cys(1)-OH)Synonyme